Peptide containing Ser-Ser-Ser-Arg

Details Peptide containing Ser-Ser-Ser-Arg Peptide containing Ser-Ser-Ser-Arg

2007-06-19

2007-06-19

Tsang, Cecilia J. (Department: 1654)

Chemistry: natural resins or derivatives; peptides or proteins;

Peptides of 3 to 100 amino acid residues

4 to 5 amino acid residues in defined sequence

C530S300000, C530S327000, C530S328000, C530S329000, C514S002600, C514S015800, C514S016700, C514S017400, C514S018700

Reexamination Certificate

active

10497628

ABSTRACT:
A peptide, wherein the peptide is selected from the group consisting of Ser-Ser-Ser-Arg (SEQ ID NO: 1),Gly-Ser-Ser-Ser-Arg-Arg-Ala-Pro (SEQ ID NO: 4),Ser-Ser-Ser-Arg-Arg (SEQ ID NO: 5),Gly-Ser-Ser-Ser-Arg (SEQ ID NO: 6),Gly-Ser-Ser-Ser-Arg-Arg (SEQ ID NO: 7),Ala-Ser-Ser-Ser-Arg-Arg-Ala-Pro (SEQ ID NO: 8),Gly-Ser-Ser-Ser-Arg-Ala-Ala-Pro (SEQ ID NO: 9) andGly-Ser-Ser-Ser-Arg-Ala-Ala-Ala-Pro (SEQ ID NO: 10),or a pharmaceutically acceptable salt thereof.

REFERENCES:
patent: 4885163 (1989-12-01), Shaar et al.
patent: 5427778 (1995-06-01), Finkanaur et al.
patent: 6221846 (2001-04-01), Nishida et al.
patent: 6310040 (2001-10-01), Bozyczko-Coyne et al.
patent: 63-233925 (1988-09-01), None
patent: 2-112 (1990-01-01), None
patent: 5-25001 (1993-02-01), None
patent: 6-48901 (1994-02-01), None
patent: 7-500839 (1995-01-01), None
patent: 10-17489 (1998-01-01), None
patent: WO 93/08826 (1993-05-01), None
patent: WO 93/23067 (1993-11-01), None
patent: WO 95/13087 (1995-05-01), None
patent: WO 97/49419 (1997-12-01), None
“analog”. Dorlands Illustrated Medical Dictionary. <http://www.mercksource.com/pp/us/cns/cns—health—library—frame.jsp?pg=/pp/us/cns/cns—hl—dorlands.jsp?pg=/pp/us/common/dorlands/dorland/dmd—a-b—00.htm&cd=3d>, accessed Jan. 7, 2006. Last indexed Aug. 31, 2002.
Jpn. J. Clinic Ophthalmol., 46, pp. 738-743 (1992).
C. Katakami, “A New Treatment for Corneal Epithelial Defects Using Fibronectin, EGF and Hyaluronic Acid”,Jpn. J. Ophthalm. Surg., 5, pp. 719-727 (1992) (with English language Abstract).
N. Takasu, “Insulin-like Growth Factor I Stimulates Inositol Phosphate Accumulation, . . . ”,J. Biol. Chem., 264, pp. 18485-18488 (1989).
P. V. Pedone et al, “Mono-and bi-allelic expression of insulin-like growth factor II gene in human muscle tumors”,Hum. Mol. Genet., 3, pp. 1117-1121 (1994).
Y. Inoue et al, “The Sequential Changes of Substance P During Acute Herpetic Keratitis in Mice”,J. Jpn. Ophthalmol. Soc., 91, pp. 982-987 (1987) (with English language Abstract).
T. Katayama, “Ocular Inflammation and Neuropeptides in Rabbit Ocular Tissue”,J. Jpn. Ophthalmol. Soc., 92, pp. 448-452 (1988) (with English language Abstract).

Affiliated with

Also associated with

Rating

Peptide containing Ser-Ser-Ser-Arg does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Peptide containing Ser-Ser-Ser-Arg, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide containing Ser-Ser-Ser-Arg will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3858394